V Levels qualifications promise to simplify the post-16 landscape, but success depends on protecting flexibility ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Capital raised -- $17.1 million in new funding was secured, including a $13 million post-quarter investment from a leading ...

For financial advisors, a good time to talk about sequence risk with clients is when markets are calm and clients are still ...

HUPO, Bruker Corporation today announced new machine learning additions to Bruker ProteoScape™ software for immunopeptidomics ...

NTT and NTT DOCOMO developed a model that uses behaviour patterns to predict intent and sharpen customer insight.

At a time when large-scale human genome analysis was not yet common, the Tohoku Medical Megabank Organization (ToMMo) ...